228 related articles for article (PubMed ID: 4347030)
21. [Herpesvirus hominis type 2 and Epstein-Barr virus antibodies in patients with cancer of the uterine cervix].
Vestergaard BF; Hornsleth A; Pedersen SN
Ugeskr Laeger; 1973 Jul; 135(27):1425-8. PubMed ID: 4357007
[No Abstract] [Full Text] [Related]
22. [Herpes simplex virus type 2 and cervix cancer].
te Velde ER; The TH
Ned Tijdschr Geneeskd; 1978 Aug; 122(33):1226-30. PubMed ID: 209356
[No Abstract] [Full Text] [Related]
23. Serological studies against herpes simplex virus types I & II in cervical carcinoma patients.
Rajeswari N; Thyagarajan SP; Kanaklata ; Rajendran P; Subramanian S; Vaideeswaran ; Shanta V
Indian J Pathol Microbiol; 1987 Apr; 30(2):157-62. PubMed ID: 2856216
[No Abstract] [Full Text] [Related]
24. IgG-, IgA- and IgM-antibodies to herpes simplex virus type 2 in sera from patients with cancer of the uterine cervix.
El Falaky IH; Vestergaard BF
Eur J Cancer (1965); 1977 Mar; 13(3):247-51. PubMed ID: 193693
[No Abstract] [Full Text] [Related]
25. [Neutralizing antibodies against type 2 herpes simplex virus in women with cervicouterine cancer].
Ruiz-Gómez J; Gallegos Vargas G; Carranza García J; Alvarez y Muñoz MT
Ginecol Obstet Mex; 1977 Dec; 42(254):369-75. PubMed ID: 233828
[No Abstract] [Full Text] [Related]
26. Sero-prevalence of herpes simplex virus type-2 among cancer cervix patients.
Lakshmi N; Kumar AG; Anand T; Reddy BK
Indian J Cancer; 1993 Dec; 30(4):189-91. PubMed ID: 8206501
[TBL] [Abstract][Full Text] [Related]
27. Herpes type-2 virus antibody status in groups of patients with neoplasm in Ibadan.
Adelusi B; Osunkoya BO; Fabiyi A
Afr J Med Med Sci; 1976 Dec; 5(4):297-301. PubMed ID: 204178
[TBL] [Abstract][Full Text] [Related]
28. Herpes virus infection and uterine cervix carcinoma. General considerations, personal experimental data and suggestions for a specific antiherpes adjuvant therapy.
Nastac E; Hozoc M; Stoian M
Virologie; 1982; 33(2):163-8. PubMed ID: 6293167
[TBL] [Abstract][Full Text] [Related]
29. Antibody to herpes simplex virus type 2-induced early antigens and its radioimmunoassay with sera of cervical carcinoma patients.
Ito H; Kurihara S; Nishimura C
Kitasato Arch Exp Med; 1978 Jun; 51(1-2):1-13. PubMed ID: 225600
[No Abstract] [Full Text] [Related]
30. [Etiological role of the herpes simplex virus in causing cervical cancer].
Posevaia TA; Shubladze AK; Grigor'ev VV; Ugriumov EP; Kitsak VIa
Vopr Virusol; 1979; (6):611-5. PubMed ID: 230645
[TBL] [Abstract][Full Text] [Related]
31. Antibodies to herpes simplex virus types 1 and 2: a comparative study using indirect haemagglutination in carcinoma of the cervix and in other malignant conditions.
Freymuth F; Morel C; Longson A; Tanguy M
Biomedicine; 1975 Sep; 23(7):271-5. PubMed ID: 182291
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of herpes simplex virus antibodies in dental students.
Rodu B; Tate AL; Lakeman AF; Mattingly G; Russell CM; Whitley RJ
J Dent Educ; 1992 Mar; 56(3):206-8. PubMed ID: 1315348
[No Abstract] [Full Text] [Related]
33. [Role of the genital herpes virus in the cancer of the cervix uteri].
Thiry L; Sprecher-Goldberger S
Bull Acad R Med Belg; 1974; 129(1 pt 2):109-41. PubMed ID: 4377231
[No Abstract] [Full Text] [Related]
34. [Herpes simplex virus type 2 antibodies in the husbans of women with cervical cancer].
Kunkel M; Oberender H; Rätz KH; Hofmann R; Gärtner L; Heise H
Z Gesamte Hyg; 1979 Aug; 25(8):597-9. PubMed ID: 228506
[No Abstract] [Full Text] [Related]
35. [Serum HSV-2 antibody in males from high and low incidence areas of cervical cancer].
Chen WK; Cheng L; Guo SF; Xiang JM
Zhonghua Zhong Liu Za Zhi; 1986 May; 8(3):199-200. PubMed ID: 3017663
[TBL] [Abstract][Full Text] [Related]
36. [Epidemiology of herpes virus type II].
Sanchís-Bayarri Vaillant V; Tejada González P
Med Clin (Barc); 1983 Jun; 80(20):875-8. PubMed ID: 6310282
[No Abstract] [Full Text] [Related]
37. A study of associated factors, including genital herpes, in Black women with cervical carcinoma in Johannesburg.
Freedman RS; Joosting AC; Ryan JT; Nkoni S
S Afr Med J; 1974 Aug; 48(41):1747-52. PubMed ID: 4369733
[No Abstract] [Full Text] [Related]
38. Herpesvirus hominis: from latency to carcinogenesis?
Aurelian L
Johns Hopkins Med J Suppl; 1973; 2():245-66. PubMed ID: 4137697
[No Abstract] [Full Text] [Related]
39. [Viral infection and cervix carcinoma].
Schneweis KE
Gynakologe; 1984 Jun; 17(2):84-7. PubMed ID: 6088372
[No Abstract] [Full Text] [Related]
40. Antibody to Herpesvirus hominis in patients with carcinoma of the cervix.
Najem SN; Barton IG; Al-Omar LS; Potter CW
Br J Exp Pathol; 1982 Oct; 63(5):485-9. PubMed ID: 6293526
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
